Catalyst

Slingshot members are tracking this event:

Aduro Biotech (ADRO) expects to submit an IND filing for antibody therapy Anti-CTLA4 in the first half of 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ADRO Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Anti-ctla-4, Ind Filing, Antibody Therapy